FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to paediatrics and immunology, and can be used for differential diagnosis of acute and chronic clinical course of infectious mononucleosis in children. For this purpose, content of malonic dialdehyde in blood serum is determined. At content of malonic dialdehyde in blood serum, equal to 3.3 mcmol/l or higher, acute course of infectious mononucleosis is diagnosed. At content of malonic dialdehyde below 3.3 mcmol/l, chronic course is diagnosed.
EFFECT: use of given method enables to differentiate acute and chronic infectious mononucleosis in children that provides timely change of therapeutic approach to patient.
1 cl, 3 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SEVERITY DETERMINATION FOR ACUTE INFECTIOUS MONONUCLEOSIS CAUSED BY EPSTEIN - BARR VIRUS IN CHILDREN | 2016 |
|
RU2625505C1 |
| METHOD FOR DIAGNOSING THE SEVERITY OF EPSTEIN-BARR VIRUS-INDUCED ACUTE INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2022 |
|
RU2797960C1 |
| METHOD OF ASSESSING THE SEVERITY OF ACUTE INFECTIOUS MONONUCLEOSIS CAUSED BY THE EPSTEIN-BARR VIRUS IN CHILDREN | 2022 |
|
RU2798079C1 |
| METHOD OF PREDICTING RELAPSE OF EPSTEIN-BARR VIRAL INFECTION IN CHILDREN | 2023 |
|
RU2820959C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF INFECTIOUS MONONUCLEOSIS OF VARIOUS ETIOLOGY AT CHILDREN | 2008 |
|
RU2360254C1 |
| METHOD FOR PREDICTION OF RECURRENT EPSTEIN-BARR VIRUS INFECTION IN CHILDREN | 2018 |
|
RU2708460C1 |
| METHOD OF DIFFERENTIAL DIAGNOSIS OF INFECTIOUS MONONUCLEOSIS OF EPSHTEIN-BARR-VIRAL ETIOLOGY, ACUTE BACTERIAL TONSILLITIS AND ACUTE VIRAL HEPATITIS “B” IN ADULTS | 2017 |
|
RU2687563C2 |
| METHOD FOR DETERMINING THERAPEUTIC APPROACH IN CHILDREN WITH ACUTE INFECTIOUS MONONUCLEOSIS | 2023 |
|
RU2821347C1 |
| METHOD FOR ASSESSING EFFECTIVENESS OF ANTIVIRAL THERAPY IN INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2023 |
|
RU2823996C1 |
| METHOD FOR ASSESSING DEGREE OF INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2017 |
|
RU2673073C1 |
